Circulating Ang-2 mRNA expression levels: looking ahead to a new prognostic factor for NSCLC [corrected].
Non-small cell lung cancer (NSCLC) is the most common cancer and the leading cause of death from cancer worldwide. Antiangiogenic strategies directed towards tumor stroma are becoming gold standard in NSCLC treatment and researchers have been searching for biomarkers to identify patients for whom th...
Guardado en:
Autores principales: | Ana L Coelho, António Araújo, Mónica Gomes, Raquel Catarino, Agostinho Marques, Rui Medeiros |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f4bc05cdbb10491bb67f27f480e0b850 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients.
por: Raquel Catarino, et al.
Publicado: (2012) -
Racial/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study
por: Ahmed Elhussein, et al.
Publicado: (2022) -
The look ahead trace back optimizer for genomic selection under transparent and opaque simulators
por: Fatemeh Amini, et al.
Publicado: (2021) -
A look-ahead Monte Carlo simulation method for improving parental selection in trait introgression
por: Saba Moeinizade, et al.
Publicado: (2021) -
Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
por: Zdeněk Kejík, et al.
Publicado: (2021)